ASLAN Pharmaceuticals Limited logo
ASLAN Pharmaceuticals Limited ASLN

Annual report 2020
added 08-19-2023

report update icon

ASLAN Pharmaceuticals Limited Market Cap 2011-2026 | ASLN

As of May 16, 2026 ASLAN Pharmaceuticals Limited has a market cap of $ 1.7 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap ASLAN Pharmaceuticals Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 85.3 M 65 M 102 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
102 M 65 M 84.1 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
50.7 M - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
226 M $ 1.57 -3.68 % $ 184 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
8.91 M - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.25 B $ 16.87 -2.49 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
29.1 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
AstraZeneca PLC AstraZeneca PLC
AZN
115 B - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
217 M $ 7.47 -4.6 % $ 205 M israelIsrael
Athira Pharma Athira Pharma
ATHA
1.62 M - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
740 M - 0.74 % $ 768 M israelIsrael
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
559 M $ 30.26 1.0 % $ 814 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
7.65 M - -32.59 % $ 7.61 M usaUSA
Exelixis Exelixis
EXEL
11.7 B $ 50.13 -1.9 % $ 13.6 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
77.8 M $ 2.41 4.78 % $ 67.2 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
1.44 B - -18.52 % $ 27.3 M britainBritain
Forte Biosciences Forte Biosciences
FBRX
335 M $ 23.11 -3.55 % $ 299 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
962 M $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
322 M $ 1.63 2.52 % $ 434 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
BioNTech SE BioNTech SE
BNTX
22 B $ 89.55 -2.65 % $ 21.6 B germanyGermany
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
52.7 M - - $ 231 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
178 M $ 2.17 -7.66 % $ 139 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
10.6 M - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
117 M - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
179 M - - $ 344 M usaUSA
IMV IMV
IMV
6.84 M - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
3.25 B - - $ 3.67 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M - - $ 7.46 M israelIsrael
Gilead Sciences Gilead Sciences
GILD
183 B $ 129.58 -1.88 % $ 161 B usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
4.81 M $ 3.36 -3.72 % $ 5.53 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
14.8 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
13.5 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M - 1.93 % $ 17.4 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
43.9 M $ 0.72 -1.58 % $ 32.9 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
561 M $ 3.12 - $ 649 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Genmab A/S Genmab A/S
GMAB
1.41 B $ 26.54 -1.34 % $ 1.72 B danmarkDanmark
Aptinyx Aptinyx
APTX
9.48 M - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
172 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
538 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
13.1 M - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
114 M - - $ 28.6 M usaUSA